Germany covid-19 vaccine infection Germany

'Just beautiful'—Another COVID-19 vaccine, from newcomer Moderna, succeeds in large-scale trial

Reading now: 957
www.sciencemag.org

Jon CohenScience’s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.Now there are two.

Another COVID-19 vaccine using the same previously unproven technology as the vaccine from Pfizer and BioNTech, the U.S and German companies that reported success on 9 November, appears to work remarkably well.

And this time the maker, the U.S. biotech Moderna, is releasing a bit more data than the other two companies to back its claim.An independent board monitoring Moderna’s 30,000-person vaccine trial met on Sunday and reported to the company and U.S.

Read more on sciencemag.org
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA